Reducing sexual health risks and substance use in the prenatal setting: A study protocol for a randomized controlled trial
Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
Golfo Tzilos Wernette1, Melissa Plegue1, Okeoma Mmeje2
1Department of Family Medicine, University of Michigan, Ann Arbor, MI 48104, United States of America.
Insights
This study evaluated a computer-delivered intervention for pregnant women to reduce risks from sexually transmitted infections (STIs) and substance use. The Health Check-Up for Expectant Moms (HCEM) aims to improve maternal and infant health outcomes.
Area of Science:
- Public Health
- Maternal Health
- Substance Use Disorders
Background:
- Sexually transmitted infections (STIs) are at record highs, posing significant risks to childbearing women, including premature birth and fetal death.
- Substance use during pregnancy is increasing, leading to adverse birth outcomes and higher likelihood of risky sexual behaviors and STIs.
- A critical gap exists in interventions addressing both STI risk and substance misuse concurrently in pregnant populations.
Purpose of the Study:
- To test the efficacy of the Health Check-Up for Expectant Moms (HCEM) computer-delivered intervention in reducing antenatal and postpartum risks.
- To compare the HCEM intervention against a matched control condition among pregnant women seeking prenatal care.
- To provide data on the effectiveness, costs, and resource utilization of a brief motivational intervention for high-risk pregnant women.
Main Methods:
- A two-group, randomized controlled trial involving 250 pregnant women recruited from prenatal care clinics.
- Participants were assigned to either a computer-delivered intervention (HCEM) with booster sessions or a computer-delivered control condition.
- Follow-up assessments included objective measures of STI incidence and birth outcomes at 2 and 6 months postpartum, and 6 weeks postpartum.
Main Results:
- The study is designed to yield crucial data on the effectiveness of the HCEM intervention.
- Objective measures of STI incidence and birth outcomes will be analyzed to determine intervention impact.
- The results will inform the costs and resource utilization associated with this practical intervention.
Conclusions:
- The findings will address a critical gap in managing co-occurring STI risk and substance use in pregnant women.
- This research will provide essential data on the efficacy of a computer-delivered motivational intervention.
- The study aims to improve maternal and infant health by offering a scalable and accessible intervention during pregnancy and postpartum.
Abstract:
Sexually transmitted infections (STIs) are at a record high in the United States, and STI risk is a critical and costly public health concern for childbearing women. STIs can lead to a number of serious health risks including premature birth, low birth weight, ectopic pregnancy, and fetal death. Similarly, there has been a dramatic increase in substance use during pregnancy, leading to complications during pregnancy and poorer birth outcomes. Women who misuse substances are disproportionately more likely to engage in risky sexual behaviors that can result in STIs. The proposed study will test whether the Health Check-Up for Expectant Moms (HCEM), a computer-delivered brief intervention that simultaneously targets STI risk and alcohol/illicit drug use during pregnancy, reduces antenatal and postpartum risk more than an attention, time, and information matched control condition among pregnant women seeking prenatal care. The study is a two-group, randomized controlled trial in which a diverse sample of 250 pregnant women will be recruited from prenatal care clinics and assigned to either (a) a computer-delivered, single-session brief intervention plus two booster sessions); or (b) a computer-delivered control condition. Follow-up assessments will occur at 2 and 6 months from baseline, and at 6 weeks postpartum. Our objective measures include STI incidence and birth outcomes. The results of this trial will fill a critical gap and provide much-needed data on the efficacy, costs, and resource utilization of a practical computer-delivered, brief motivational intervention tailored to reach high-risk women during pregnancy and extending impact to postpartum.
Related Concept Videos
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Deleterious Substances in Aggregate
Another type of impurity is clay and fine material that...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sexually Transmitted Infections
Clinical Trials
There are four phases in a clinical trial. A phase one...

